BingX hints the launch of Seraph (SRF) Coin as it shifts it’s attention to WEB3 games and Gamefi
SINGAPORE - Media OutReach Newswire - 22 December 2023 - BingX, a top copytrading cryptocurrency…
3 years ago
Novo Nordisk Pharma (Thailand) Ltd. Clinches Triple Triumph at Asia Pacific Enterprise Awards 2023 Thailand
SINGAPORE - Media OutReach Newswire - 22 December 2023 - Novo Nordisk Pharma (Thailand) Ltd.…
3 years ago
Kumwell Corporation Public Company Limited and CEO Boonsak Kiatjaroonlert’s Double Triumphs at the Asia Pacific Enterprise Awards 2023 Thailand
SINGAPORE - Media OutReach Newswire - 22 December 2023 - Local manufacturer and distributor Kumwell…
3 years ago
HKQAA International Symposium “Sustainable Finance, ESG and Climate Resilience • Hong Kong 2023” Successfully Held
Promotes Sustainable Finance, Facilitates ESG Ecosystem Development HONG KONG SAR - Media OutReach Newswire -…
3 years ago
FPT Hits One Billion USD Revenue in Global IT Services for the First Time
HANOI, Vietnam--(BUSINESS WIRE)--#AI--Global technology corporation FPT has surpassed one billion USD in the global IT…
3 years ago
Fashion Icon Rihanna Makes Power Move, Unleashing a Global Fashion Sensation
HONG KONG SAR - Media OutReach Newswire - 22 December 2023 - As the year…
3 years ago
Novo Nordisk topping the list of the Best Places to Work in Thailand for 2023
BANGKOK, THAILAND - Media OutReach Newswire - 22 December 2023 - Novo Nordisk Thailand topped…
3 years ago
MDRT and the MDRT Foundation Donate to Aidha and Make-a-Wish Singapore
In support of MDRT’s membership and in the spirit of giving, representatives from MDRT and…
3 years ago
Rare Element Resources Receives DOE Approval to Proceed with Construction of Rare Earth Processing and Separation Demonstration Plant
Plant Operations Expected to Commence in 2024 LITTLETON, Colo.--(BUSINESS WIRE)--Rare Element Resources Ltd. (the “Company 
3 years ago
Takeda Announces China NMPA Approval of LIVTENCITY® (maribavir) for the Treatment of Adults With Post-transplant Cytomegalovirus (CMV) Refractory to Prior Therapies
- LIVTENCITY Is the First and Only Inhibitor of CMV-specific UL97 Protein Kinase Approved in…
3 years ago